LPTI Longport Inc (CE)

Longport, Inc. (OTCBB:LPTI), a medical technology specialist in high frequency high resolution ultrasound imaging, today announced the implementation of a clinical study at two Montana skilled nursing care centers in partnership with the Goodman Group. The principal investigator, Dr. Karen Zulkowski, will explore the use of Longport's EPISCAN I-200 for improved clinical detection of pressure ulcer risk and development. Dr. Zulkowski is a professor of nursing at Montana State University-Bozeman and is a member of the National Pressure Ulcer Advisory Panel (NPUAP). Dr. Zulkowski said, "Current practice involves the examination of a patient's skin for signs of pressure ulcers by sight. The use of this new technology will allow health care practitioners to identify and treat tissue damage much earlier, well before we can see changes on the skin's surface. This research is a wonderful opportunity for Montana to be a leader in the use of this groundbreaking technology." Valley Health Care and Rehabilitation Center and Billings Health and Rehabilitation Community, operated by the Goodman Group, have been assets to the Billings health care community for more than 35 years. The hallmarks of the skilled nursing centers go beyond the gracious living spaces provided for residents, updating the communities to stay in tune with modern care philosophies and changing healthcare technology has always been a priority for both communities. Karen Powers of the Goodman Group said, "We are always ready to be the leading innovators in long term care, the communities continually look ahead to new care technologies that could enhance residents' lives. Long known for its special staffing and attention in wound care management, Valley Health and Billings Health are happy to partner with Longport Inc to pilot a new program for preventative wound care management." For more information on any of these programs please contact Valley Health Care and Rehabilitation Center at 406-656-5010 or Billings Health and Rehabilitation Community at 406-656-6500. Connie Phillips-Jones, Director of Clinical Support said, "This initiative is a part of Longport, Inc.'s strategy of gathering clinical study data to open new markets for our technology using evidence-based information." About Longport, Inc. Longport, Inc. of Glen Mills, Pennsylvania, is a medical technology company that specializes in high resolution ultrasound imaging. After several years and a multi-million dollar investment in the technology, Longport has secured patents, copyrights, and FDA permission to market. The Company's technology has been used to engineer a unique high resolution ultrasound imaging system. For further information please contact Longport, Inc. at 1-800-289-6863 or visit our website at www.longportinc.com. Forward-looking Information and the Private Securities Litigation Reform Act of 1995 Certain statements in this press release, including statements concerning product development milestones and anticipated events, are "forward-looking statements" within the Private Litigation Reform Act of 1995. Forward Looking Statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect Longport's actual results include, among others, uncertainties as to the Company's ability to manage potential problems, delays or anticipated expenses, including problems, delays or expenses involving manufacturing. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only to the date of this release. Reference is made to Longport's 2004 annual report on Form 10-K filed with the Securities and Exchange Commission for a more definitive description of such factors. Longport, Inc. undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.